News and Press Releases

Contact Veristat Now


Request A Proposal

Contact Us

Veristat Presents Integrated, Customized DCT Solutions at the DTRA Annual Meeting

Highlights the unique advantages its DCT solutions hold for small to mid-size biotechs conducting trials for complex diseases 

 

Read More

Veristat Joins Decentralized Trials & Research Alliance (DTRA) to Improve the Patient Experience

Advances commitment to support patient needs across diverse populations

 

Read More

Veristat is Recognized on the 2022 Inc. 5000 List of America’s Fastest-Growing Private Companies

Veristat’s Bold Thinking and World Class Clinical, Regulatory and Commercialization Capabilities Allow the Company to Successfully Tackle Complex Therapy Development Challenges to Meet the Goals of its Clients

 

Read More

Veristat congratulates Awakn - UK State Funding to Identify Optimal Pathway to Market In UK & US

Veristat congratulates Awakn for being awarded UK State Funding to Identify Optimal Pathway to Market In UK & US For Its Lead Clinical Development Program – Ketamine-Assisted Therapy For Alcohol Use Disorder

Read More

Cindy Henderson Named Veristat Chief Commercial Officer

Instrumental to Veristat’s growth, success, and client satisfaction over the last 15 years

 

Read More

Veristat Launches Strategic Resourcing to Build Greater Flexibility in its Suite of Engagement Models

Providing sponsors expert staff to accelerate milestones and support study success

 

Read More

Veristat Expands its Expertise and Scale across Biopharma and Medtech

Acquires Swiss-based multi-disciplinary consultancy SFL (Solutions for Life Sciences) to accelerate the development of and access to innovative treatments

 

Read More

Veristat Appoints Joe Scott as Chief Financial Officer

Accomplished Financial Executive to Drive Company’s Next Phase of Growth

 

Read More

Veristat Supported Marketing Applications for 12% of all FDA Novel Drug Approvals in 2021

Bridging the Gap between Trial and Treatment by Supporting the Approval of Several Novel Therapies for Rare Diseases

 

Read More